223 related articles for article (PubMed ID: 30872612)
41. Role of EGFL7 in human cancers: A review.
de Oliveira C; Gonçalves PG; Bidinotto LT
J Cell Physiol; 2023 Aug; 238(8):1756-1767. PubMed ID: 37490307
[TBL] [Abstract][Full Text] [Related]
42. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
[TBL] [Abstract][Full Text] [Related]
43. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
[TBL] [Abstract][Full Text] [Related]
44. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
Xian Y; Wang X; Yu Y; Chen X
Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
[TBL] [Abstract][Full Text] [Related]
45. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
[TBL] [Abstract][Full Text] [Related]
46. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma.
Tsou PS; Khanna D; Sawalha AH
Arthritis Rheumatol; 2019 Aug; 71(8):1350-1359. PubMed ID: 30884213
[TBL] [Abstract][Full Text] [Related]
47. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
48. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
[TBL] [Abstract][Full Text] [Related]
49. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
[TBL] [Abstract][Full Text] [Related]
50. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
[TBL] [Abstract][Full Text] [Related]
51. B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.
Cicchillitti L; Jimenez SA; Sala A; Saitta B
Biochem J; 2004 Mar; 378(Pt 2):609-16. PubMed ID: 14613485
[TBL] [Abstract][Full Text] [Related]
52. Increased accumulation of extracellular thrombospondin-2 due to low degradation activity stimulates type I collagen expression in scleroderma fibroblasts.
Kajihara I; Jinnin M; Yamane K; Makino T; Honda N; Igata T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
Am J Pathol; 2012 Feb; 180(2):703-14. PubMed ID: 22142808
[TBL] [Abstract][Full Text] [Related]
53. Perivascular Cells in Diffuse Cutaneous Systemic Sclerosis Overexpress Activated ADAM12 and Are Involved in Myofibroblast Transdifferentiation and Development of Fibrosis.
Cipriani P; Di Benedetto P; Ruscitti P; Liakouli V; Berardicurti O; Carubbi F; Ciccia F; Guggino G; Zazzeroni F; Alesse E; Triolo G; Giacomelli R
J Rheumatol; 2016 Jul; 43(7):1340-9. PubMed ID: 27252423
[TBL] [Abstract][Full Text] [Related]
54. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
[TBL] [Abstract][Full Text] [Related]
55. Serum microRNAs in Systemic Sclerosis, Associations with Digital Vasculopathy and Lung Involvement.
Wajda A; Walczyk M; Dudek E; Stypińska B; Lewandowska A; Romanowska-Próchnicka K; Chojnowski M; Olesińska M; Paradowska-Gorycka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142646
[No Abstract] [Full Text] [Related]
56. Genome-Wide Reduction in Chromatin Accessibility and Unique Transcription Factor Footprints in Endothelial Cells and Fibroblasts in Scleroderma Skin.
Tsou PS; Palisoc PJ; Ali M; Khanna D; Sawalha AH
Arthritis Rheumatol; 2021 Aug; 73(8):1501-1513. PubMed ID: 33586346
[TBL] [Abstract][Full Text] [Related]
57. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692
[TBL] [Abstract][Full Text] [Related]
58. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
Kubo M; Ihn H; Yamane K; Tamaki K
J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
[TBL] [Abstract][Full Text] [Related]
59. Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon.
Higley H; Persichitte K; Chu S; Waegell W; Vancheeswaran R; Black C
Arthritis Rheum; 1994 Feb; 37(2):278-88. PubMed ID: 7510487
[TBL] [Abstract][Full Text] [Related]
60. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]